We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
MindBio Therapeutics Corp | CSE:MBIO | CSE | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | |
---|---|---|---|---|---|
-0.005 | -8.33% | 0.055 | 0.05 | 0.07 |
High Price | Low Price | Open Price | Shares Traded | Last Trade |
---|---|---|---|---|
0.065 | 0.055 | 0.06 | 79,200 | 21:00:13 |
Date | Time | Source | Headline |
---|---|---|---|
24/8/2023 | 14:00 | IHNW | Mindbio Therapeutics Begins Dosing MB22001 In Phase 2 Clinical Trial In.. |
14/6/2023 | 13:00 | IHNW | MindBio Therapeutics Breakthrough Discovery in Microdosing Clinical Trial.. |
30/5/2023 | 13:00 | IHNW | MindBio Therapeutics CEO Demonstrates how 1 Million Microdoses of LSD can.. |
23/5/2023 | 13:15 | IHNW | MindBio Therapeutics Ethics Approval for Landmark World First Phase 2.. |
11/5/2023 | 13:29 | IHNW | MindBio Therapeutics Phase 2 Clinical Trial Has Received Ethics Approval.. |
09/5/2023 | 14:13 | IHNW | MindBio Therapeutics Corp (CSE: MBIO) Reveals Scientific Paper in.. |
1 Year MindBio Therapeutics Chart |
Intraday MindBio Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions